20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is OMEPRAZOLE, USP, with a corresponding US DMF Number 29402.
Remarkably, this DMF maintains an Active status since its submission on June 22, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 11, 2015, and payment made on June 17, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II